$Anavex Life Sciences (AVXL.US)$Reuters· just New Phase Iib/III Clinical Data Demonstrates Over Three Years of Continuous Treatment With Oral Blarcamesine to Significantly Benefit Early Alzheimer’s Disease Patients
Here are the levels to watch as AVXL continues to drift lower after the large move last week. Support at 10.33 for now. 11.55 level to get over. $Anavex Life Sciences (AVXL.US)$
1
Report
Rhiox
:
looking at the day chart, still to be on an uptrend even after this pullback. my opinion this needs these pull backs for a healthy uptrend to continue.
EmotionOutofEquation
:
Looks like forcast trajectory is good almost 400% past 8-9 month being clinical stage and no revenue is only problem for long term investment but they narrowing losses as decreasing negetive cash flow current year not bad performance
Hi mooers! Need a quick update on this week's events? Check out moomoo's fresh earnings & economic calendars to start this week! For more details, check out the earnings calendar and economic calendar! This week, various companies including$Anavex Life Sciences (AVXL.US)$,$Limoneira (LMNR.US)$and$Venu Holding (VENU.US)$are releasing their earnings. How will the market react to the companies' results? Let's keep our eyes peeled and see who will shine b...
16
Report
No comment yet
Sign in to post a comment
Trending Stocks
Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Anavex Life Sciences Stock Forum
New Phase Iib/III Clinical Data Demonstrates Over Three Years of Continuous Treatment With Oral Blarcamesine to Significantly Benefit Early Alzheimer’s Disease Patients
$Anavex Life Sciences (AVXL.US)$
I would like to wish everyone a Happy New Year
Need a quick update on this week's events? Check out moomoo's fresh earnings & economic calendars to start this week!
For more details, check out the earnings calendar and economic calendar!
This week, various companies including $Anavex Life Sciences (AVXL.US)$ , $Limoneira (LMNR.US)$ and $Venu Holding (VENU.US)$ are releasing their earnings. How will the market react to the companies' results? Let's keep our eyes peeled and see who will shine b...
No comment yet